Silvia Cernea Clark

Rice and the Houston Methodist Research Institute have signed a memorandum of understanding with LSE Health at the London School of Economics and Political Science to explore collaboration on an interdisciplinary training program for future global health care leaders.

Rice's Akane Sano has been selected for the first class of the Chief of Naval Research Fellows program.

Rice researchers engineered a living factory.

Rice researchers developed a new way to model how the cochlea processes incoming sound using graph signal processing, which could shed light on what happens as hearing deteriorates with age and make possible better assistive technologies for people with hearing loss.

The Brain Health for Economic Resilience Commission, convened in collaboration with Nature Medicine, was announced at the Texas Brain Economy Summit June 9–10.

A new study by researchers at Rice and Baylor reveals that the brain maintains a geometric neural “map” for meaning that allows multilingual speakers to express themselves across languages.

Rice researchers have developed a high-throughput method to measure the quality of diamond and other wide-bandgap semiconductor materials, providing rapid feedback for improving crystal growth and device reliability.

Rice bioengineer Julea Vlassakis has won $1.1M in federal funding for a project researching Ewing sarcoma.

The Houston Methodist-Rice Digital Health Institute recently welcomed Frank Marchetti, Consul General of France in Houston, and his team to discuss health care innovation and avenues for international collaboration.

Rice researchers demonstrated a new kind of wireless jamming attack that uses curved radio signals to disguise where interference is coming from.

Rice scientists successfully assembled carbon nanotubes with the same chiral orientation into large high-quality crystals that can manipulate light with an efficiency two to three orders of magnitude greater than conventional materials.

Rice researchers have developed extremely stable perovskite crystalline films for long-lasting, high-efficiency solar cells.

Rice researchers engineered a new version of a well-known multiferroic that exhibits orders of magnitude higher performance at room temperature than its parent material.

Motif Neurotech, a company commercializing technology based on research at Rice, has received approval from the FDA to begin the first clinical trial of its therapeutic brain-computer interface for treatment of treatment-resistant depression.

An internal seed funding initiative will support 12 projects exploring brain health research.

The Houston Methodist Rice Digital Health Institute hosted its inaugural HMRDHI Industry Translation Day, marking a significant milestone in the institute’s mission to accelerate the discovery, development and clinical deployment of digital health innovations.

Rep. Brian Babin (R-Woodville), chairman of the House Committee on Science, Space and Technology, visited Rice March 20 with a delegation of congressional staff to tour research facilities and learn about areas of focus across the university.

Rice scientists have created a new type of 2D semiconductor that comes closer than ever to a “perfect” crystal.

Rice researchers and collaborators have now successfully integrated solutions to several persistent challenges to implantable drug factories into a single device.

A new platform makes it easier to study metastasis and sheds light on how cancer clusters survive in the bloodstream when spreading from a primary tumor to other parts of the body.